Next Article in Journal
Deoxynivalenol in the Gastrointestinal Tract of Immature Gilts under per os Toxin Application
Next Article in Special Issue
Extracellular Hb Enhances Cardiac Toxicity in Endotoxemic Guinea Pigs: Protective Role of Haptoglobin
Previous Article in Journal
The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
Previous Article in Special Issue
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
Article Menu

Export Article

Open AccessReview
Toxins 2014, 6(3), 950-972;

Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy

Integrated BioTherapeutics Inc., 21 Firstfield Rd., Gaithersburg, MD 20878, USA
Author to whom correspondence should be addressed.
Received: 16 December 2013 / Revised: 22 February 2014 / Accepted: 26 February 2014 / Published: 4 March 2014
(This article belongs to the Collection Toxicity and Therapeutic Interventions in the Immune System)
Full-Text   |   PDF [348 KB, uploaded 4 March 2014]   |  


Staphylococccus aureus represents one of the most challenging human pathogens as well as a common colonizer of human skin and mucosal surfaces. S. aureus causes a wide range of diseases from skin and soft tissue infection (SSTI) to debilitating and life-threatening conditions such as osteomyelitis, endocarditis, and necrotizing pneumonia. The range of diseases reflects the remarkable diversity of the virulence factors produced by this pathogen, including surface antigens involved in the establishment of infection and a large number of toxins that mediate a vast array of cellular responses. The staphylococcal toxins are generally believed to have evolved to disarm the innate immune system, the first line of defense against this pathogen. This review focuses on recent advances on elucidating the biological functions of S. aureus bicomponent pore-forming toxins (BCPFTs) and their utility as targets for preventive and therapeutic intervention. These toxins are cytolytic to a variety of immune cells, primarily neutrophils, as well as cells with a critical barrier function. The lytic activity of BCPFTs towards immune cells implies a critical role in immune evasion, and a number of epidemiological studies and animal experiments relate these toxins to clinical disease, particularly SSTI and necrotizing pneumonia. Antibody-mediated neutralization of this lytic activity may provide a strategy for development of toxoid-based vaccines or immunotherapeutics for prevention or mitigation of clinical diseases. However, certain BCPFTs have been proposed to act as danger signals that may alert the immune system through an inflammatory response. The utility of a neutralizing vaccination strategy must be weighed against such immune-activating potential. View Full-Text
Keywords: Staphylococcus aureus; pore-forming toxin; leukotoxins; leukocidins; hemolysin; vaccine; immunotherapy; PVL; LukAB; LukED; HlgAB; HlgCB Staphylococcus aureus; pore-forming toxin; leukotoxins; leukocidins; hemolysin; vaccine; immunotherapy; PVL; LukAB; LukED; HlgAB; HlgCB

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Aman, M.J.; Adhikari, R.P. Staphylococcal Bicomponent Pore-Forming Toxins: Targets for Prophylaxis and Immunotherapy. Toxins 2014, 6, 950-972.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top